GLP-1 weight loss drugs have quickly moved from medical journals to household conversations, reshaping how Americans think ...

Recent research published in the journal Diabetes sheds new light on the cellular mechanisms causing insulin resistance in type 2 diabetes, a disease affecting more than 1.2 million people in Quebec ...

Share on Pinterest Experts say California’s new affordable insulin program is a breakthrough for people with diabetes. Getty Images California has launched a program to manufacture and sell lower-cost ...

California Gov. Gavin Newsom announces CalRx-branded insulin glargine pens available beginning Jan. 1, 2026, at a suggested retail price of no more than $55 per five-pack, or $11 per pen, during a ...

Californians will be able to buy low-cost, state-branded insulin next year, Gov. Gavin Newsom announced Thursday. The CalRX – California's program to develop and sell its own prescription medications ...

This is read by an automated voice. Please report any issues or inconsistencies here. Gov. Gavin Newsom said $11 insulin pens will soon be available through the state’s pharmaceutical label.

An innovative ‘smart insulin’ may offer people living with type 1 diabetes improved treatment options to regulate blood glucose levels. This is the discovery of researchers at Indiana University, who ...

In an expansion of its previous moves to cut insulin prices, Sanofi will cap the price of each of its insulin products at $35 per month in the U.S. regardless of a patient's insurance status. The move ...

The information on this website may assist you in making personal decisions about insurance, but it is not intended to provide advice regarding the purchase or use of any insurance or insurance ...

A new treatment for type 1 diabetes is moving closer to reality. In late 2024, a 46-year-old Swedish man received 17 injections of a unique pancreatic cell cocktail. The cells, donated from a healthy ...

What just happened? The dream of a cure for type 1 diabetes may have taken a step closer after a man with the disease received a transplant of genetically altered pancreatic cells that allowed his ...